Silence Therapeutics plc
SLN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $121 | $69 | $55 | $74 |
| Short-Term Investments | $26 | $0 | $16 | $0 |
| Receivables | $27 | $24 | $1 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $10 | $25 | $12 |
| Total Curr. Assets | $187 | $103 | $97 | $86 |
| Property Plant & Equip (Net) | $2 | $2 | $2 | $2 |
| Goodwill | $9 | $10 | $8 | $8 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $4 | $0 | $0 |
| Total NC Assets | $15 | $16 | $11 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $203 | $119 | $108 | $96 |
| Liabilities | – | – | – | – |
| Payables | $4 | $3 | $3 | $4 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $1 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $7 | $0 | $0 |
| Other Curr. Liab. | $12 | $12 | $18 | $11 |
| Total Curr. Liab. | $17 | $22 | $22 | $15 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $52 | $75 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $63 | $73 |
| Total NC Liab. | $52 | $75 | $63 | $73 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $69 | $97 | $85 | $88 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $10 | $9 | $5 | $4 |
| Retained Earnings | -$474 | -$432 | -$263 | -$223 |
| AOCI | -$12 | $40 | $53 | $43 |
| Other Equity | $610 | $405 | $227 | $184 |
| Total Equity | $134 | $22 | $22 | $9 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $203 | $119 | $108 | $96 |
| Net Debt | -$121 | -$68 | -$54 | -$73 |